Response to Letter to Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy
- PMID: 34778940
- DOI: 10.1007/s12975-021-00967-5
Response to Letter to Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy
Comment on
-
Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy.Transl Stroke Res. 2020 Dec;11(6):1185-1202. doi: 10.1007/s12975-020-00806-z. Epub 2020 Mar 26. Transl Stroke Res. 2020. PMID: 32219729 Review.
-
Letter to Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy.Transl Stroke Res. 2022 Jun;13(3):357-358. doi: 10.1007/s12975-021-00965-7. Epub 2021 Nov 4. Transl Stroke Res. 2022. PMID: 34734357 No abstract available.
References
-
- Li H, Chen G. Letter to Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy. Transl Stroke Res. 2021. https://doi.org/10.1007/s12975-021-00965-7 . Epub ahead of print.
-
- Datta A, Sarmah D, Mounica L, Kaur H, Kesharwani R, Verma G, et al. Cell death pathways in ischemic stroke and targeted pharmacotherapy. Transl Stroke Res. 2020;11(6):1185–202.
-
- Kowalski RG, Haarbauer-Krupa JK, Bell JM, Corrigan JD, Hammond FM, Torbey MT, et al. Acute ischemic stroke after moderate to severe traumatic brain injury: incidence and impact on outcome. Stroke. 2017;48:1802–9. - DOI
-
- Campbell BC, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke Nat Rev Dis Primers. 2019;5:1–22. - DOI
-
- Sarmah D, Kaur H, Saraf J, Pravalika K, Goswami A, Kalia K, et al. Getting closer to an effective intervention of ischemic stroke: the big promise of stem cell. Transl Stroke Res. 2018;9:356–74. - DOI
Publication types
MeSH terms
LinkOut - more resources
Medical